Barnas E, Skret-Magierlo J, Paszek S, Kaznowska E, Potocka N, Skret A
Genes (Basel). 2023; 14(3).
PMID: 36980984
PMC: 10048324.
DOI: 10.3390/genes14030712.
Chuang T, Quintanilla D, Boos D, Khorram O
Reprod Sci. 2022; 29(10):2960-2976.
PMID: 35641855
PMC: 9537225.
DOI: 10.1007/s43032-022-00981-4.
Wu J, Sun K, Chen Z, He Y, Sheng L
J Oncol. 2022; 2022:5680353.
PMID: 35096062
PMC: 8791735.
DOI: 10.1155/2022/5680353.
Zhao W, Zhao Y, Chen L, Sun Y, Fan S
Comput Math Methods Med. 2022; 2022:2329576.
PMID: 35082911
PMC: 8786540.
DOI: 10.1155/2022/2329576.
Turner B, Cramer S, Heller D, Tavassoli F
Virchows Arch. 2021; 480(3):645-654.
PMID: 34725735
DOI: 10.1007/s00428-021-03225-z.
Macrophages and Immune Responses in Uterine Fibroids.
Zannotti A, Greco S, Pellegrino P, Giantomassi F, Delli Carpini G, Goteri G
Cells. 2021; 10(5).
PMID: 33922329
PMC: 8146588.
DOI: 10.3390/cells10050982.
MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2.
Dong X, Li Y, Cao R, Xu H
Biochem Genet. 2021; 59(4):1033-1048.
PMID: 33630202
DOI: 10.1007/s10528-021-10044-z.
Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants.
Favaro R, Morales-Prieto D, Herrmann J, Sonnemann J, Schleussner E, Markert U
Arch Gynecol Obstet. 2021; 303(6):1513-1522.
PMID: 33575847
PMC: 8087607.
DOI: 10.1007/s00404-020-05940-5.
The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids-From Bench to Bedside.
Ciebiera M, Wlodarczyk M, Zgliczynski S, Lozinski T, Walczak K, Czekierdowski A
Int J Mol Sci. 2020; 21(8).
PMID: 32344726
PMC: 7216240.
DOI: 10.3390/ijms21083016.
Phthalate Exposures and MicroRNA Expression in Uterine Fibroids: The FORGE Study.
Zota A, Geller R, VanNoy B, Marfori C, Tabbara S, Hu L
Epigenet Insights. 2020; 13:2516865720904057.
PMID: 32128507
PMC: 7031793.
DOI: 10.1177/2516865720904057.
Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorska D, Skovierova H, Brany D, Halasova E, Dankova Z
Int J Mol Sci. 2019; 20(15).
PMID: 31387281
PMC: 6695893.
DOI: 10.3390/ijms20153825.
MiR-150-5p May Contribute to Pathogenesis of Human Leiomyoma via Regulation of the Akt/p27 Pathway In Vitro.
Lee J, Choi Y, Park J, Kim H, Lee I, Won Y
Int J Mol Sci. 2019; 20(11).
PMID: 31159158
PMC: 6601023.
DOI: 10.3390/ijms20112684.
Bioinformatic analysis of miR-4792 regulates flavone to inhibit proliferation, invasion, and induce apoptosis of A549 cells.
Liu P, Pu J, Zhang J, Chen Z, Wei K, Shi L
Onco Targets Ther. 2019; 12:1401-1412.
PMID: 30863107
PMC: 6389004.
DOI: 10.2147/OTT.S182525.
MicroRNA Dysregulation and Steroid Hormone Receptor Expression in Uterine Tissues of Rats with Endometriosis during the Implantation Window.
Cai H, Zhu X, Li Z, Zhu Y, Lang J
Chin Med J (Engl). 2018; 131(18):2193-2204.
PMID: 30203794
PMC: 6144856.
DOI: 10.4103/0366-6999.240808.
Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?.
Dos Anjos L, De Almeida B, de Almeida T, Mourao Lavorato Rocha A, Maffazioli G, Soares F
Cancers (Basel). 2018; 10(9).
PMID: 30200635
PMC: 6162723.
DOI: 10.3390/cancers10090315.
Variation in MicroRNA Expression Profile of Uterine Leiomyoma with Endometrial Cavity Distortion and Endometrial Cavity Non-Distortion.
Kim Y, Kim Y, Shin J, Kim H, Ku S, Suh C
Int J Mol Sci. 2018; 19(9).
PMID: 30149651
PMC: 6165274.
DOI: 10.3390/ijms19092524.
Analysis of change in microRNA expression profiles of lung cancer A549 cells treated with Radix tetrastigma hemsleyani flavonoids.
Liu P, Yang X, Zhang H, Pu J, Wei K
Onco Targets Ther. 2018; 11:4283-4300.
PMID: 30100735
PMC: 6065472.
DOI: 10.2147/OTT.S164276.
Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma.
Chuang T, Xie Y, Yan W, Khorram O
Fertil Steril. 2018; 109(5):919-929.
PMID: 29778390
PMC: 6445395.
DOI: 10.1016/j.fertnstert.2018.01.034.
Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma.
Chuang T, Khorram O
Reprod Sci. 2018; 26(2):250-258.
PMID: 29642801
PMC: 6728566.
DOI: 10.1177/1933719118768692.
Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence.
DSouza A, Chevillet J, Ghanouni P, Yan X, Tewari M, Gambhir S
PLoS One. 2018; 13(3):e0194268.
PMID: 29547636
PMC: 5856340.
DOI: 10.1371/journal.pone.0194268.